SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Norris Medicines Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.`91. The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs. 5 Crore in December, 1993 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995. In 2006, the Company launched Diabetic & Cardiac products; launched Dental product in 2007; launched New Molecule Tolperisone with Paracetamol tablet in 2012; in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet & dry syrup. During the year 2013-14, the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and operate 2 plants situated at GIDC, Ankleshwar, Gujarat. Both plants of the Company are WHO GMP approved. At present, it has renovated the Sterile Injectable Plant and with this the plant is now as per international standards.
Norris Medicines share price as on 13 Jul 2025 is Rs. 17.95. Over the past 6 months, the Norris Medicines share price has decreased by 4.27% and in the last one year, it has increased by 22.11%. The 52-week low for Norris Medicines share price was Rs. 12.57 and 52-week high was Rs. 27.74.
524414
INE744C01029
Sep
Norris Medicines Ltd FAQs
You can buy Norris Medicines Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Norris Medicines Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jul 11, 2025 04:01 PM the closing price of Norris Medicines Ltd was Rs.17.95.
The latest PE ratio of Norris Medicines Ltd as of Jul 11, 2025 04:01 PM is 0.00
The latest PB ratio of Norris Medicines Ltd as of Jul 11, 2025 04:01 PM is -0.82
The 52-week high of Norris Medicines Ltd share price is Rs. 27.74 while the 52-week low is Rs. 12.57
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 11, 2025 04:01 PM, the market cap of Norris Medicines Ltd stood at Rs. 17.95 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.